Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Interruption to antiplatelet therapy early after acute ischaemic stroke: a nested case-control study.

Mazlan-Kepli W, Macisaac RL, Walters M, Bath PMW, Dawson J; VISTA Collaborators.

Br J Clin Pharmacol. 2017 Sep;83(9):2045-2055. doi: 10.1111/bcp.13290. Epub 2017 Apr 20.

PMID:
28299795
2.

Objectives and Design of BLEEDS: A Cohort Study to Identify New Risk Factors and Predictors for Major Bleeding during Treatment with Vitamin K Antagonists.

van Rein N, Lijfering WM, Bos MH, Herruer MH, Vermaas HW, van der Meer FJ, Reitsma PH.

PLoS One. 2016 Dec 9;11(12):e0164485. doi: 10.1371/journal.pone.0164485. eCollection 2016.

3.

Impact of Triple Therapy in Elderly Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.

Sambola A, Mutuberría M, García Del Blanco B, Alonso A, Barrabés JA, Bueno H, Alfonso F, Cequier A, Zueco J, Rodríguez-Leor O, Tornos P, García-Dorado D.

PLoS One. 2016 Jan 25;11(1):e0147245. doi: 10.1371/journal.pone.0147245. eCollection 2016.

4.

The Association Between Bleeding and the Incidence of Warfarin Discontinuation in Patients with Atrial Fibrillation.

Simon TA, Pan X, Kawabata H, Huang HY, Azoulay L.

Cardiovasc Ther. 2016 Apr;34(2):94-9. doi: 10.1111/1755-5922.12174.

5.

Inappropriate combination of warfarin and aspirin.

Turan B, Demir H, Mutlu A, Daşlı T, Erkol A, Erden İ.

Anatol J Cardiol. 2016 Mar;16(3):189-96. doi: 10.5152/akd.2015.6050. Epub 2015 Apr 24.

6.

Neuraxial and peripheral nerve blocks in patients taking anticoagulant or thromboprophylactic drugs: challenges and solutions.

Li J, Halaszynski T.

Local Reg Anesth. 2015 Aug 4;8:21-32. doi: 10.2147/LRA.S55306. eCollection 2015. Review.

7.

Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association.

Meschia JF, Bushnell C, Boden-Albala B, Braun LT, Bravata DM, Chaturvedi S, Creager MA, Eckel RH, Elkind MS, Fornage M, Goldstein LB, Greenberg SM, Horvath SE, Iadecola C, Jauch EC, Moore WS, Wilson JA; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Functional Genomics and Translational Biology; Council on Hypertension.

Stroke. 2014 Dec;45(12):3754-832. doi: 10.1161/STR.0000000000000046. Epub 2014 Oct 28.

8.

Polypharmacy is associated with an increased risk of bleeding in elderly patients with venous thromboembolism.

Leiss W, Méan M, Limacher A, Righini M, Jaeger K, Beer HJ, Osterwalder J, Frauchiger B, Matter CM, Kucher N, Angelillo-Scherrer A, Cornuz J, Banyai M, Lämmle B, Husmann M, Egloff M, Aschwanden M, Rodondi N, Aujesky D.

J Gen Intern Med. 2015 Jan;30(1):17-24. doi: 10.1007/s11606-014-2993-8. Epub 2014 Aug 21.

9.

Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation).

Goodman SG, Wojdyla DM, Piccini JP, White HD, Paolini JF, Nessel CC, Berkowitz SD, Mahaffey KW, Patel MR, Sherwood MW, Becker RC, Halperin JL, Hacke W, Singer DE, Hankey GJ, Breithardt G, Fox KA, Califf RM; ROCKET AF Investigators.

J Am Coll Cardiol. 2014 Mar 11;63(9):891-900. doi: 10.1016/j.jacc.2013.11.013. Epub 2013 Dec 4.

10.

Assessing bleeding risk in patients taking anticoagulants.

Shoeb M, Fang MC.

J Thromb Thrombolysis. 2013 Apr;35(3):312-9. doi: 10.1007/s11239-013-0899-7. Review.

11.

Major bleeding in patients with atrial fibrillation receiving vitamin K antagonists: a systematic review of randomized and observational studies.

Roskell NS, Samuel M, Noack H, Monz BU.

Europace. 2013 Jun;15(6):787-97. doi: 10.1093/europace/eut001. Epub 2013 Feb 13. Review.

12.

Atrial fibrillation and thromboprophylaxis in heart failure: the need for patient-centered approaches to address adherence.

Ferguson C, Inglis SC, Newton PJ, Middleton S, Macdonald PS, Davidson PM.

Vasc Health Risk Manag. 2013;9:3-11. doi: 10.2147/VHRM.S39571. Epub 2013 Jan 16. Review.

13.

Stroke prevention with oral anticoagulation in older people with atrial fibrillation - a pragmatic approach.

Ali A, Bailey C, Abdelhafiz AH.

Aging Dis. 2012 Aug;3(4):339-51. Epub 2012 Jun 21.

14.

Pharmacokinetic and pharmacodynamic effects of comedication of clopidogrel and dabigatran etexilate in healthy male volunteers.

Härtter S, Sennewald R, Schepers C, Baumann S, Fritsch H, Friedman J.

Eur J Clin Pharmacol. 2013 Mar;69(3):327-39. doi: 10.1007/s00228-012-1304-8. Epub 2012 Jul 11.

15.

Preventing stroke in atrial fibrillation patients - clinical utility of oral anticoagulants.

Jhawar MB, Flaker G.

J Blood Med. 2012;3:1-13. doi: 10.2147/JBM.S19827. Epub 2012 Apr 12.

16.

Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Holbrook A, Schulman S, Witt DM, Vandvik PO, Fish J, Kovacs MJ, Svensson PJ, Veenstra DL, Crowther M, Guyatt GH.

Chest. 2012 Feb;141(2 Suppl):e152S-e184S. doi: 10.1378/chest.11-2295. Review.

17.

A systematic review of validated methods for identifying atrial fibrillation using administrative data.

Jensen PN, Johnson K, Floyd J, Heckbert SR, Carnahan R, Dublin S.

Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:141-7. doi: 10.1002/pds.2317. Review.

18.

Association between CHADS₂risk factors and anticoagulation-related bleeding: a systematic literature review.

Chen WT, White CM, Phung OJ, Kluger J, Ashaye AO, Sobieraj DM, Makanji S, Tongbram V, Baker WL, Coleman CI.

Mayo Clin Proc. 2011 Jun;86(6):509-21. doi: 10.4065/mcp.2010.0755. Review.

19.

Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies.

Crandall MA, Bradley DJ, Packer DL, Asirvatham SJ.

Mayo Clin Proc. 2009 Jul;84(7):643-62. doi: 10.1016/S0025-6196(11)60754-4. Review.

20.

Don't add aspirin for associated stable vascular disease in a patient with atrial fibrillation receiving anticoagulation.

Lip GY.

BMJ. 2008 Mar 15;336(7644):614-5. doi: 10.1136/bmj.39351.706586.AD. Review. No abstract available.

Supplemental Content

Support Center